Three thousand Washingtonians died of overdoses in 2024 and more than 40% of these deaths involved fentanyl mixed with other substances. At the same time, there are still statewide opportunities to examine acute opioid prescribing practices for our pediatric population – an especially vulnerable patient group.
Hospitals are uniquely positioned to lead efforts in addressing the ongoing public health crisis driven by fentanyl and the long-term effects of acute opioid prescribing in children. This July, WSHA is offering two opportunities to develop solutions and support initiatives aimed at reducing harm from opioid misuse.
First, the Opioid Harm Prevention Workgroup meets next Monday, July 14 from noon-1 p.m. This bi-monthly forum gathers hospital leaders for updates, problem solving and collaboration on strategies like improved opioid prescribing practices, naloxone distribution and treatment access through prescribing medications for opioid use disorder (MOUD).
Then on July 28, WSHA will launch the Opioid Stewardship DELTA Collaborative, a six-month initiative focused on reducing acute opioid prescribing, especially in pediatric care. With opioid prescribing in Washington still 22% above guidelines, this collaborative offers hospitals a data-driven, peer-supported path to improvement through a multipronged approach to both upstream prescribing and downstream overdose prevention and treatment.
Hospitals across Washington can lead the fight against opioid misuse. By participating in WSHA’s upcoming initiatives, your organization can help reduce unnecessary opioid exposure, protect pediatric patients and expand access to effective treatment.
Sincerely,
Brittany Weiner
WSHA Director, Safety and Quality
Brittanyw@wsha.org